BeyondSpring Inc.
BYSI
$1.34
-$0.16-10.67%
Weiss Ratings | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E+ | |||
Rating Factors | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Weak | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.91 | |||
Price History | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -10.07% | |||
30-Day Total Return | -25.14% | |||
60-Day Total Return | -22.09% | |||
90-Day Total Return | -22.99% | |||
Year to Date Total Return | -15.72% | |||
1-Year Total Return | -48.46% | |||
2-Year Total Return | 19.64% | |||
3-Year Total Return | -49.62% | |||
5-Year Total Return | -89.69% | |||
52-Week High % Change | -58.62% | |||
52-Week Low % Change | 9.49% | |||
Price | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $3.63 | |||
52-Week Low Price | $1.37 | |||
52-Week Low Price (Date) | Mar 31, 2025 | |||
52-Week High Price (Date) | May 24, 2024 | |||
Valuation | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 60.47M | |||
Enterprise Value | 76.76M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.11 | |||
Earnings Per Share Growth | -80.27% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -1.78 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $1.34 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -- | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 39.73M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 646 305 6387 | |||
Address | 100 Campus Drive Florham Park, NJ 07932 | |||
Website | beyondspringpharma.com | |||
Country | United States | |||
Year Founded | 2010 | |||
Profitability | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -- | |||
Return on Equity | -- | |||
Income Statement | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -- | |||
Net Income (TTM) | -- | |||
Net Income Avl. to Common (TTM) | -- | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -- | |||
EPS Diluted (TTM) | -- | |||
EPS Diluted Growth (Q YOY) | -- | |||
Balance Sheet | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.92M | |||
Cash Per Share (Q) | $0.07 | |||
Total Current Assets (Q) | 28.58M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -14.29M | |||
Current Ratio (Q) | 2.596 | |||
Book Value Per Share (Q) | -$0.84 | |||
Total Assets (Q) | 34.32M | |||
Total Current Liabilities (Q) | 11.01M | |||
Total Debt (Q) | 589.00K | |||
Total Liabilities (Q) | 48.60M | |||
Total Common Equity (Q) | -32.90M | |||
Cash Flow | BYSI - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | -- | |||
Net Change in Cash (TTM) | -- | |||
Levered Free Cash Flow (TTM) | -- | |||
Cash from Operations (TTM) | -- | |||